Trial intelligence / Profile preview

Preoperative oral medications for outcomes after impacted lower wisdom tooth extraction

RBR-5h8w5fwPhase 3Not yet recruiting

Sponsor
Federal University of Rio de Janeiro
Start
Oct 2026
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, triple-blind trial of dexamethasone, etoricoxib and amoxicillin in Impacted lower third molar (4 arms), sponsored by Federal University of Rio de Janeiro. Planned start Oct 2026; status: not yet recruiting.

02

Drugs

dexamethasoneetoricoxibamoxicillin
03

Conditions

Impacted lower third molar

Beyond the preview

Go deeper on RBR-5h8w5fw.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-5h8w5fw.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call